Metraipolis › archive › dc_386eed6f1ba2

Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients) — Europe PMC PMID:30583686

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/30583686
DOI
10.31557/apjcp.2018.19.12.3581
License (as archived)
solo-consultazione
Archived
2026-11-04T03:55:29.186Z
SHA-256 of the archived text
2882506cfd94d4829786eeb1754fa453cd333f70c38aeddb91c91780409639dc
Stable URL of this page
https://metraipolis.com/documento/dc_386eed6f1ba2

How to cite

Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients) — Europe PMC PMID:30583686 — Europe PMC (en), https://europepmc.org/article/MED/30583686 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_386eed6f1ba2 (Metraipolis archive dc_386eed6f1ba2, sha256 2882506cfd94d4829786eeb1754fa453cd333f70c38aeddb91c91780409639dc)
BibTeX
@misc{dc386eed6f1ba2,
  title = {Topoisomerase II α Gene alteration in Triple Negative Breast Cancer and Its Predictive Role for Anthracycline-Based Chemotherapy (Egyptian NCI Patients) — Europe PMC PMID:30583686},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/30583686},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_386eed6f1ba2; sha256 2882506cfd94d4829786eeb1754fa453cd333f70c38aeddb91c91780409639dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/30583686. Agents can read the archived copy with the MCP tool read_document.